Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. - Wikidata - awgldk - TriplyDB

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

http://www.wikidata.org/entity/Q34160359

about

MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults Blood lead is a predictor of homocysteine levels in a population-based study of older adults Fortification of wheat and maize flour with folic acid for population health outcomes Homocysteine-lowering interventions for preventing cardiovascular events Interventions for lowering plasma homocysteine levels in kidney transplant recipients Homocysteine-lowering interventions for preventing cardiovascular events Homocysteine lowering interventions for preventing cardiovascular events Interventions for lowering plasma homocysteine levels in dialysis patients Interventions for lowering plasma homocysteine levels in kidney transplant recipients Structural basis for mammalian vitamin B12 transport by transcobalamin A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis Cobalamin deficiency, hyperhomocysteinemia, and dementia Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study A strategy to reduce cardiovascular disease by more than 80%Elevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjects The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans.A folate-rich diet is as effective as folic acid from supplements in decreasing plasma homocysteine concentrations.Interventions for lowering plasma homocysteine levels in dialysis patients Multidisciplinary approach and anesthetic management of a surgical cancer patient with methylene tetrahydrofolate reductase deficiency: a case report and review of the literature The role of vitamin supplementation in the prevention of cardiovascular disease events Results of observational studies: analysis of findings from the Nurses' Health Study Genome-wide association study of selenium concentrations Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure Novel therapies for the prevention of stroke Hypothyroidism in coronary heart disease and its relation to selected risk factors Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease Association of endothelial nitric oxide synthase gene polymorphisms (894G/T, -786T/C, G10T) and clinical findings in patients with migraine Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis Association of blood lead concentrations with mortality in older women: a prospective cohort study Lead exposure, B vitamins, and plasma homocysteine in men 55 years of age and older: the VA normative aging study Ethnic differences in the prevalence of high homocysteine levels among low-income rural Kazakh and Uyghur adults in far western China and its implications for preventive public health Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis

P2860

Q21245922-7030D3C1-1517-46D5-91EB-7A4D336748A1 Q23915647-7DCB1C5C-8454-49D8-BD86-62DA14387376 Q24185965-C121F94E-4F41-419A-9D57-88070D11DB54 Q24186605-3EC964EE-1C61-4D04-8924-0833076D2AB2 Q24188051-E80D2C29-B025-4B9F-BC52-8B107D0E27E7 Q24201783-8A86B0BE-C6C6-4C28-8016-7843AFD53892 Q24239981-76809F27-09B1-4CE1-966D-63FC72D33FB0 Q24240554-BC537300-3CE8-483B-9304-63F86AEA2932 Q24240632-2C8F07D1-FF94-499D-A255-F602D6961942 Q24307771-3F172838-5D89-4713-95C6-207068FB203C Q24530955-0C6C347A-CAC3-4CD7-8BAE-3D0A0220D406 Q24604736-75919A52-A3CE-43D3-BDF5-3905DF92993B Q24609123-86887526-7300-413D-A2DB-6F989059FD5E Q24644637-AE22F116-1861-4D83-B0FD-40D30FC78B5F Q24647967-06D13D1F-9A0E-4A83-B4DA-313B7E8DB945 Q24679592-16E080B5-72D8-4D37-AC0A-9E885D44E066 Q24791309-C7B7A56D-42F8-459B-85F3-F3649AFE254F Q24803265-2F9BDCC1-A710-42CD-8CB2-C5BE0E027A1B Q24810064-CEBCD9CE-E8F3-41E5-A937-81B838C530DE Q24810330-36F44012-741D-4527-8299-D7DF087B7B65 Q26471859-0F425236-96E5-438E-9D8C-B47EFDA0B21D Q26796387-B8FE2613-7B68-45D5-9B97-45C67B782B15 Q26852596-A0658079-94B4-4088-AB4E-3449A94980E9 Q27006022-AB456DF2-4A08-4D11-A0A7-850177E98748 Q27301096-D70F2845-E4D6-4FE2-80EB-FD60982F3939 Q27694579-E7B24664-2A48-411E-B63D-56C84EAE695D Q28070413-96141540-8DAC-4C84-BBC5-D2F04A39864A Q28074234-AB205AD1-8C11-4D14-BE09-1DBD72419255 Q28210724-99394CF6-E316-422A-9A10-063700A55808 Q28219425-8A9708D9-13C4-4E80-8C3A-4832560178B9 Q28220999-3DC01B86-0A2F-4600-853E-9AAE554560D3 Q28240463-217A49C2-F834-4626-BF29-D6A4BEC1FAE5 Q28259237-0C49E956-ACE6-4DEB-8AE6-0FDECFC96D2E Q28386310-B93A97AA-63B6-4906-8DFC-B6A53B436D4C Q28388302-3C361117-F3CE-4A5E-BE1C-57A066195295 Q28395111-8A85CFB6-67B8-46F8-9667-820616C08704 Q28395558-45502794-4593-4856-933C-632283938874 Q28472816-21D1A7AD-F3DB-4B0F-A3AC-57D8832F8B6F Q28731901-A4DDA6E8-46FF-47BD-A01A-2B327E12D5C2 Q28743107-202C3659-F22E-4C90-93FC-5906AC6E8D9F

P2860

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

http://www.wikidata.org/entity/Q34160359

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@ast

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@en

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@nl

type

label

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@ast

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@en

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@nl

prefLabel

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@ast

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@en

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@nl

P1433

Q34160359-769B93DF-80C5-429C-A711-74E8BA4FAB0D

P1476

Q34160359-94E909BD-D8E2-40DC-8A6E-DC3B58B0EE60

P2093

Q34160359-A211948A-93ED-452F-9924-EB5A8ADBA395

Q34160359-B5D96AAE-8F20-4BC4-97EA-9472B9918212

Q34160359-EA398C56-7D3E-4D4A-9790-640A52B99A08

P2860

Q34160359-06C6C342-14A7-40E1-A45A-7269609221D2

Q34160359-3A9611F4-3FCB-4CDD-ADF5-3ED5EE74D692

Q34160359-3B6C95FE-D05E-465D-9367-9A2F7AFC4EAA

Q34160359-3C7FAE65-3472-46C5-A956-F07C0F183235

Q34160359-410948B8-7719-4BDE-B578-88F431C7585F

Q34160359-4C528EAB-E404-4F8A-9675-9F29D3048F8E

Q34160359-63831FBC-3E26-4EE3-BD4D-4E4980ABBC86

Q34160359-90F82B0B-D7B0-4426-9E32-0029307DDCD1

Q34160359-98CFF9EB-5823-44FF-8651-0918FF2770EF

Q34160359-A533029D-FA51-47DA-8597-0620E8D8317B

P304

Q34160359-A518A077-AC4B-46DC-917C-F5E872DDED20

P31

Q34160359-1654934b-17dd-4126-9d58-1f5218936721

Q34160359-2143530A-7344-46D1-8810-44652BEF3113

P356

Q34160359-1C710DA6-38E7-4D45-8AE6-7B73F39B143F

P407

Q34160359-2C5683B6-5216-44EB-950C-C5CE57C414C1

P433

Q34160359-EEDF667F-E400-4AD0-B5ED-98C9A96F0A1D

P478

Q34160359-634699DD-C816-4787-8009-7A569C79CA4B

P577

Q34160359-0CFA9B1B-C3C7-405D-B7FD-B65E525C31D6

P5875

Q34160359-DE84E4A9-5129-4D7E-A982-37CCCF5CB9FC

P698

Q34160359-3182CA3F-15B7-480C-B5D4-3EB3CF4FF54C

P921

Q34160359-37409D78-9152-491B-B46A-328C4110F1D2

Q34160359-5132C01D-81EF-487E-B596-C8F621CAF49F

P932

Q34160359-F02B901C-B0E0-413F-B7A0-A0D77869FDAE

P356

BMJ.325.7374.1202

P1433

P1476

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

@en

P2093

David S Wald

http://www.w3.org/2001/XMLSchema#string

Joan K Morris

http://www.w3.org/2001/XMLSchema#string

Malcolm Law

http://www.w3.org/2001/XMLSchema#string

P2860

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

Risk factor thresholds: their existence under scrutiny

Bias in meta-analysis detected by a simple, graphical test

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

Randomized trial of folic acid supplementation and serum homocysteine levels.

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.

Homocysteine and cardiovascular disease: cause or effect?

The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations.

The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.

The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

P304

1202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.325.7374.1202

http://www.w3.org/2001/XMLSchema#string

P407

P433

7374

http://www.w3.org/2001/XMLSchema#string

P478

325

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11021730

http://www.w3.org/2001/XMLSchema#string

P698

12446535

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

135491

http://www.w3.org/2001/XMLSchema#string